Schedule 13G ownership disclosure

ProQR Therapeutics NV

Security class unavailable · CUSIP: N71542109

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,495,128
Percent of class
11.1300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-20-000297
Form type
SC 13G/A
Filer
ProQR Therapeutics N.V.
CIK
CIK 1612940
Filed
Jan 28, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub